Evidence map›Paper›PMID 38993230›Full record

ArticleData in brief2024

First draft genome sequence data of TA4-1, the type strain of Gram-positive bacterium

Montri Yasawong, A'liyatur Rosyidah, Thunwarat Songngamsuk, Manassanan Phatcharaharikarn, Phongsakorn Ganta, Panjamaphon Chanthasena, Nuannoi Chudapongse, Napatsorn Santapan, Wissarut Srisakvarangkool, Supavadee Kerdtoob and 1 more

Abstract read
In one paragraph

Article in Data in brief, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Montri YasawongProgramme on Environmental Toxicology, Chulabhorn Graduate Institute, Chulabhorn Royal Academy, Bangkok 10210, Thailand.
A'liyatur RosyidahResearch Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Bogor 16911, Indonesia.
Thunwarat SongngamsukProgramme on Environmental Toxicology, Chulabhorn Graduate Institute, Chulabhorn Royal Academy, Bangkok 10210, Thailand.
Manassanan PhatcharaharikarnProgramme on Environmental Toxicology, Chulabhorn Graduate Institute, Chulabhorn Royal Academy, Bangkok 10210, Thailand.
Phongsakorn GantaSchool of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
Panjamaphon ChanthasenaFaculty of Allied Health Sciences, Nakhonratchasima College, Nakhon Ratchasima 30000, Thailand.
Nuannoi ChudapongseDepartment of Basic Medical Sciences, Faculty of Medicine, Siam University, Bangkok 10160, Thailand.
Napatsorn SantapanSchool of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
Wissarut SrisakvarangkoolSchool of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
Supavadee KerdtoobFaculty of Allied Health Sciences, Nakhonratchasima College, Nakhon Ratchasima 30000, Thailand.
Nawarat NantapongSchool of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TA4-1 is the type strain of

Indexed as

DesferrioxamineFlaviolinNonribosomal peptidePolyketideTerpeneType strain

Identifiers

PMID38993230
PMCPMC11237854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.